Author/Creator: LaCreta, Frank - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator LaCreta, Frank

1. Apixaban Single‐Dose Pharmacokinetics, Bioavailability, Renal Clearance, and Pharmacodynamics Following Intravenous and Oral Administration. Issue 9 (2nd August 2021)

Authors:: Frost, Charles; Garonzik, Samira; Shenker, Andrew; Barrett, Yu Chen; LaCreta, Frank
Journal:: Clinical pharmacology in drug development
Issue:: Volume 10:Issue 9(2021)
Page Start:: 974
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Apixaban, an oral, direct factor Xa inhibitor: single dose safety, pharmacokinetics, pharmacodynamics and food effect in healthy subjects. (10th January 2013)

Authors:: Frost, Charles; Wang, Jessie; Nepal, Sunil; Schuster, Alan; Barrett, Yu Chen; Mosqueda‐Garcia, Rogelio; Reeves, Richard A.; LaCreta, Frank
Journal:: British journal of clinical pharmacology
Issue:: Volume 75:Number 2(2013:Feb.)
Page Start:: 476
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Bioequivalence of saxagliptin/dapagliflozin fixed‐dose combination tablets compared with coadministration of the individual tablets to healthy subjects. Issue 6 (12th January 2016)

Authors:: Vakkalagadda, Blisse; Vetter, Marion L.; Rana, Jignasa; Smith, Charles H.; Huang, Jian; Karkas, Jennifer; Boulton, David W.; LaCreta, Frank
Journal:: Pharmacology research & perspectives
Issue:: Volume 3:Issue 6(2015 Dec)
Page Start:: n/a
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Dosing Recommendation Based on the Effects of Different Meal Types on Pexidartinib Pharmacokinetics in Healthy Subjects: Implementation of Model‐informed Drug Development Strategy. Issue 5 (21st March 2023)

Authors:: Zahir, Hamim; Yin, Ophelia; Hsu, Ching; Wagner, Andrew J.; Jiang, Jason; Wang, Xiaoning; Greenberg, Jon; Shuster, Dale E.; Kakkar, Tarundeep; LaCreta, Frank
Journal:: Clinical pharmacology in drug development
Issue:: Volume 12:Issue 5(2023)
Page Start:: 475
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Effect of ketoconazole and diltiazem on the pharmacokinetics of apixaban, an oral direct factor Xa inhibitor. (May 2015)

Authors:: Frost, Charles E.; Byon, Wonkyung; Song, Yan; Wang, Jessie; Schuster, Alan E.; Boyd, Rebecca A.; Zhang, Donglu; Yu, Zhigang; Dias, Clapton; Shenker, Andrew; LaCreta, Frank
Journal:: British journal of clinical pharmacology
Issue:: Volume 79:Number 5(2015:May)
Page Start:: 838
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. Effect of Mild and Moderate Hepatic Impairment (Defined by Child–Pugh Classification and National Cancer Institute Organ Dysfunction Working Group Criteria) on Pexidartinib Pharmacokinetics. (31st March 2022)

Authors:: Zahir, Hamim; Greenberg, Jonathan; Hsu, Ching; Marbury, Thomas C.; Lasseter, Kenneth C.; Xu, Li‐An; Tap, William D.; Healey, John H.; Stacchiotti, Silvia; LaCreta, Frank
Journal:: Journal of clinical pharmacology
Issue:: Volume 62:Number 8(2022)
Page Start:: 992
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

7. Effect of renal impairment on the pharmacokinetics, pharmacodynamics, and safety of apixaban. (4th December 2015)

Authors:: Chang, Ming; Yu, Zhigang; Shenker, Andrew; Wang, Jessie; Pursley, Janice; Byon, Wonkyung; Boyd, Rebecca A.; LaCreta, Frank; Frost, Charles E.
Journal:: Journal of clinical pharmacology
Issue:: Volume 56:Number 5(2016)
Page Start:: 637
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

8. Evaluation of the effect of naproxen on the pharmacokinetics and pharmacodynamics of apixaban. (October 2014)

Authors:: Frost, Charles; Shenker, Andrew; Gandhi, Mohit D.; Pursley, Janice; Barrett, Yu Chen; Wang, Jessie; Zhang, Donglu; Byon, Wonkyung; Boyd, Rebecca A.; LaCreta, Frank
Journal:: British journal of clinical pharmacology
Issue:: Volume 78:Number 4(2014:Oct.)
Page Start:: 877
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

9. Exposure‐Response Relationships in Patients With HER2‐Positive Metastatic Breast Cancer and Other Solid Tumors Treated With Trastuzumab Deruxtecan. Issue 4 (10th June 2021)

Authors:: Yin, Ophelia; Iwata, Hiroji; Lin, Chia‐Chi; Tamura, Kenji; Watanabe, Junichiro; Wada, Russ; Kastrissios, Helen; AbuTarif, Malaz; Garimella, Tushar; Lee, Caleb; Zhang, Lin; Shahidi, Javad; LaCreta, Frank
Journal:: Clinical pharmacology & therapeutics
Issue:: Volume 110:Issue 4(2021)
Page Start:: 986
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

10. Model‐based assessments of CYP3A‐mediated drug‐drug interaction risk of milademetan. Issue 6 (23rd June 2021)

Authors:: Hong, Ying; Ishizuka, Tomoko; Watanabe, Akiko; Tachibana, Masaya; Lee, Mark; Ishizuka, Hitoshi; LaCreta, Frank; Abutarif, Malaz
Journal:: Clinical and translational science
Issue:: Volume 14:Issue 6(2021)
Page Start:: 2220
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗